Trial Information
The Use of Adrenalectomy in Patients With Solitary Adrenal Gland Metastases
Inclusion Criteria:
- Metastatic disease to the adrenal gland
Exclusion Criteria:
- Primary adrenal neoplasm
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Outcome Measure:
Adrenalectomy improves overall survival in patients with solitary metastasis
Outcome Description:
Survival data compared to historic controls
Outcome Time Frame:
25 years
Safety Issue:
No
Principal Investigator
Melanie L Richards, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Mayo Clinic
Authority:
United States: Institutional Review Board
Study ID:
09-007747
NCT ID:
NCT01135238
Start Date:
November 2009
Completion Date:
November 2010
Related Keywords:
- Adrenal Gland Metastases
- Adrenalectomy
- adrenalectomy
- metastasis
- morbidity
- mortality
- survival
- Neoplasm Metastasis
- Neoplasms, Second Primary
- Adrenal Gland Neoplasms